's Avatar

@bioaccess.bsky.social

21 Followers  |  108 Following  |  4 Posts  |  Joined: 19.11.2025  |  1.607

Latest posts by bioaccess.bsky.social on Bluesky


Preview
Behind the FDA Approval of Dordaviprone, a New Hope for Glioma Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Behind the FDA approval of Dordaviprone (Modeyso) lies new hope for patients with #glioma. The first FDA-approved systemic therapy for H3 K27M-mutant diffuse midline glioma marks a milestone for children & young adults facing this rare, aggressive brain tumour.

www.targetedonc.com/view/behind-...

25.08.2025 07:29 — 👍 1    🔁 1    💬 1    📌 0
Preview
NIH cuts affected over 74,000 patients enrolled in experiments, report finds Between the end of February and mid-August, funding lapsed for 383 studies that were testing treatments for conditions like cancer, heart disease and brain disease.

Between the end of February and mid-August, funding ceased for 383 studies that were testing treatments for conditions including cancer, heart disease and brain disease. https://to.pbs.org/47KbPDE

17.11.2025 22:31 — 👍 192    🔁 132    💬 11    📌 20
Post image

A beautiful tribute from CJ Carr: 100 Years of Love in 5 Years of Life
open.substack.com/pub/biotecha...

22.11.2025 01:13 — 👍 0    🔁 1    💬 0    📌 0
Post image

The Outliers Who Reshape Treatments and Patient Access
open.substack.com/pub/biotecha...

20.11.2025 21:13 — 👍 0    🔁 0    💬 0    📌 0
Preview
When One Patient Changes Everything FDA's new plausible mechanism pathway

When One Patient Changes Everything
open.substack.com/pub/biotecha...

19.11.2025 11:13 — 👍 0    🔁 0    💬 0    📌 0
Post image

When the Ground Shifts: FDA Volatility and the Real Cost to Patients
open.substack.com/pub/biotecha...

19.11.2025 01:44 — 👍 1    🔁 0    💬 0    📌 0

@bioaccess is following 20 prominent accounts